Cardiology Heart Disease Press Releases

New Vein Clinic to Open With A Mission to Make Your Legs Look Great

New Vein Clinic to Open With A Mission to Make Your Legs Look Great

A new clinic serving Arizona's communities will open in August to help clients walk with greater confidence - by removing embarrassing and troublesome varicose veins. The Scottsdale Elite Vein Clinic, based out of 3226 N Miller Rd Suite #5D, will…

Dr. Rajamannan Reports to Northwestern University, Chicago IL VP: COVID-19 Non-Compliance in Clinical Trials

Dr. Rajamannan Reports to Northwestern University, Chicago IL VP: COVID-19 Non-Compliance in Clinical Trials

Most Sacred Heart of Jesus Cardiology and Valvular Institute Director Dr. Nalini Rajamannan, has submitted evidence in an open letter to Northwestern University’s Newly Minted Vice President for Research Dr. Milan Mrksich, the Senate Finance Committee, the Senate Committee on Homeland Security, the FDA…

Dr. Rajamannan Sends New Evidence to the White House to Protect US Citizens From Faulty Heart Valves as Presented to the FDA on March 9, 2020

Dr. Rajamannan Sends New Evidence to the White House to Protect US Citizens From Faulty Heart Valves as Presented to the FDA on March 9, 2020

On Monday, March 9, 2020, 11:00 a.m., CBS News recorded an FDA conference call with Dr. Nalini Rajamannan, Most Sacred Heart of Jesus Cardiology, Mayo Medical School Graduate and Adjunct Visiting Scientist, Mayo Clinic. The FDA called the meeting on…

Fort Myers Vein Specialist Offers Varicose Surgery

Fort Myers Vein Specialist Offers Varicose Surgery

Are you suffering from unsightly veins or vascular health issues? Then Fort Myers-based Dr Chris Meyer is ready and waiting to help you regain your confidence with their vein care. The difference with Dr Meyer, who runs Fort Myers Varicose…

Radcliffe Group Ltd Appoints Non-Executive Chairman and Chief Scientific Officer

Radcliffe Group Ltd Appoints Non-Executive Chairman and Chief Scientific Officer

​​​​​​​​​​​​​​Radcliffe Group Ltd (“RG”) announces Professor Andrew Coats (recently Academic Vice President, Monash University and University of Warwick) as Non-Executive Chairman and Dr. Gregory Guillory as Chief Scientific Officer, effective on April 1, 2019.  Professor Andrew Coats (top right) is a world-renowned Australian–British academic cardiologist…

Concept Medical Inc. Granted 'Breakthrough Device Designation' From FDA for Its MagicTouch Sirolimus Coated Balloon

Concept Medical Inc. Granted 'Breakthrough Device Designation' From FDA for Its MagicTouch Sirolimus Coated Balloon

Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch, its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of coronary in-stent restenosis (ISR). In-stent restenosis (ISR) is the gradual re-narrowing…

Florida Specialist offers ‘Vein Regain’ with Varicose Surgery

Florida Specialist offers ‘Vein Regain’ with Varicose Surgery

Are you suffering from unsightly veins or vascular health issues? Then Dr Chris Meyer and his team of experts are ready and waiting to help you regain your confidence with their vein care. The difference with Dr Meyer, who runs…

Florida doctors solve the embarrassment of varicose veins

Florida doctors solve the embarrassment of varicose veins

Are you suffering from the pain and discomfort of spider and varicose veins? Then why not join the thousands of satisfied patients who can now walk out in the sun, in shorts and confidence thanks to the Florida Vein Care…

Rising Prevalence of Hypertension Spurs Global Growth in New Therapies

Rising Prevalence of Hypertension Spurs Global Growth in New Therapies

Projected growth of the global antihypertensives market to 2023 is attributed to the growing prevalence of hypertension, an increase in government programs for prescription drugs, and investments by key players in the development of novel therapies. The global market for…

Radcliffe Cardiology Confirms PubMed Indexing for European Cardiology Review (ECR)

Radcliffe Cardiology Confirms PubMed Indexing for European Cardiology Review (ECR)

European Cardiology Review (ECR) confirms that it has been accepted for indexing on PubMed Central and PubMed. Published under Radcliffe Cardiology’s ownership, all ECR articles starting from the first issue in July 2014 will now be published online in full on PubMed Central, providing greater exposure and…

$1,250,000 Fraud Verdict in Pradaxa Blood Thinner Trial in Huntington, West Virginia

Andy Childers of Childers, Schleuter & Smith of Atlanta, Georgia, and Neal Moskow of Ury & Moskow are pleased to announce that they recovered a $1,250,000 fraud verdict for the Betty Knight family. The case, Knight vs. Boehringer Ingelheim Pharmaceuticals, Inc., was…

Concept Medical Inc. Raises $60mn for Investigational Device Exemption (IDE) for the World's First Sirolimus-Coated Balloon

​Concept Medical Inc. Raises $60mn For Investigational Device Exemption (IDE) For The World's First Sirolimus-Coated Balloon. Concept Medical Inc. (CMI) has approached the FDA for an Investigational Device Exemption (IDE) for their Sirolimus-Coated Balloon (DCB). To support this process, they…

Radcliffe Cardiology Announces New Partnership With the British Heart Rhythm Society

Radcliffe Cardiology's Arrhythmia & Electrophysiology Review (AER) Journal announces the launch of an official partnership with the British Heart Rhythm Society (BHRS). As the official journal of the BHRS, Arrhythmia & Electrophysiology Review, a Radcliffe Cardiology Journal, will be disseminated directly to BHRS members…

US Cardiology Review (USC) Journal Appoints Dr. Ankur Kalra as New Editor-in-Chief

US Cardiology Review (USC) Journal announces the appointment of USC's new Editor-in-Chief, Dr. Ankur Kalra effective from Sept. 6. Dr. Kalra is a Clinical Assistant Professor of Medicine (Cardiology) at Case Western Reserve University School of Medicine, and a staff cardiologist at Harrington Heart…

Radcliffe Cardiology Confirm PubMed Central Indexing for Interventional Cardiology Review (ICR)

Interventional Cardiology Review (ICR) confirms it has been accepted for indexing on PubMed Central and PubMed. All articles published under Radcliffe Cardiology’s ownership from volumes 8.1 (2013) to 13.1 (2018) are now available in full on this important index, providing…

Solstice Joined AHA to Celebrate 15th National Wear Red Day

Solstice Joined AHA to Celebrate 15th National Wear Red Day

Solstice Benefits, Inc., (Solstice) joined hearts with many other groups around the country this past Friday, Feb. 2, 2018, to celebrate National Wear Red Day. Employees of the dental and vision insurer showed up to work on Friday, vibrant in red…

Body Composition in Clinical Trials – From BMI to MRI, New Webinar Hosted by Xtalks

Body Composition in Clinical Trials – From BMI to MRI, New Webinar Hosted by Xtalks

In a live session upcoming on Tuesday, February 13, 2018 at 11 a.m. EST, experts from Biotelemetry and AMRA will discuss alternative methods to BMI for determining body composition in clinical trials. Webinar Details: Body Composition in Clinical Trials –…

BlueCross, Microclinic International Partner to Improve Health of Tennesseans

The BlueCross BlueShield of Tennessee Health Foundation awards grants annually to organizations working to improve the health of Tennesseans. Microclinic International, a recipient of one of these grants, offers training clinics in disease prevention and management to foster healthy habits…

CorMatrix Cardiovascular Announces Sale of First Pipeline Assets

CorMatrix Cardiovascular, Inc. (www.cormatrix.com), a leader in cardiovascular tissue engineering, today announces the sale of its pipeline first-to-market regenerative devices to Aziyo Biologics. CorMatrix, a developer of extracellular matrix cardiovascular devices, has sold over 160,000 devices to the market since…

Cancer-Cardiac Connection Illuminates Promising New Drug for Heart Failure

Cancer-Cardiac Connection Illuminates Promising New Drug for Heart Failure

A team of researchers at the Gladstone Institutes uncovered a new strategy to treat heart failure, a leading contributor to mortality and healthcare costs in the United States. Despite widespread use of currently-approved drugs, approximately 40% of patients with heart…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login